Key takeways
Antidepressant withdrawal can last from a few days to many months, and longer use raises the risk of prolonged symptoms.
A drug clearing the body does not mean the brain has readjusted, so withdrawal symptoms can persist long after the last dose.
Withdrawal can start weeks after a dose change and include low mood, so it is often mistaken for depression coming back.
How Long Does Antidepressant Withdrawal Last: The Honest Range
Antidepressant withdrawal lasts anywhere from a few days to many months, and for some people longer. It is highly individual: some have mild symptoms for days or weeks, while many have prolonged symptoms often mistaken for relapse. Longer use, short half-life drugs, past withdrawal and stopping abruptly raise the risk.
Consider someone who has taken an antidepressant for 12 years and, with their clinician, comes off it over about a month. The first week feels fine. Then the dizziness starts, along with crying spells that seem to come from nowhere and nights of broken sleep. By week six, they are told the depression is back. It may not be. The timing and the type of symptoms point somewhere else, and telling the two apart changes what happens next.
Why Withdrawal Symptoms Can Outlast the Drug
The Brain Adapts to Having the Medication There
Taking an antidepressant every day leads the brain to adapt to it. Over months and years, the brain makes changes to live with the drug, countering its effects to keep things steady. When the dose falls, those changes are still in place. The gap between what the brain has adjusted to and what it now receives is what people feel as withdrawal (Horowitz & Taylor, 2024). Reversing those changes is the brain adjusting to the absence of the medication, and it runs on its own schedule.
The dose itself matters in a way that surprises many people. PET imaging shows that SSRIs occupy roughly 80% of serotonin transporters at their minimum therapeutic doses, and occupancy rises steeply at low doses and plateaus at higher doses (Meyer et al., 2004). So each milligram has a larger effect on the serotonin transporter at low doses than at high doses (Horowitz & Taylor, 2019). That is why the last few milligrams are often the hardest, and why reductions that get progressively smaller make pharmacological sense. We explain the method itself in our guide to what hyperbolic tapering is and how it works.
Why Half-Life Is Not the Timeline
Half-life is how long the body takes to clear half of a drug from the blood. It shapes when acute symptoms tend to start: drugs that leave the body faster, such as Paxil (paroxetine) and Effexor (venlafaxine), tend to cause symptoms sooner after a missed or reduced dose. But the drug clearing the body does not mean the brain's adaptations have reversed. Symptoms can continue for weeks or months as the brain adjusts to the absence of the medication, so the risk of prolonged withdrawal remains even after the medication has cleared. "It should be out of your system by now" is not a reason to dismiss what you are feeling.
What the Research Says About Duration
For years, guidance described withdrawal as mild and over within a week or two. The evidence gathered since then paints a wider picture. A 2019 systematic review found that across 14 studies, an average of 56% of people who stopped antidepressants experienced withdrawal effects (range 27% to 86%) (Davies & Read, 2019). On duration, seven of ten studies reporting it found that a significant proportion of people experience withdrawal for more than two weeks, and it is not uncommon for symptoms to last several months. In the four large studies that measured severity, an average of 46% of people who experienced withdrawal rated it at the most severe level offered. That review mixed study designs, including self-selected online surveys, and its estimates have been publicly debated, so read the numbers as a range rather than a forecast.
A more recent survey looked at people in routine care. In a 2025 survey of 310 patients in England's National Health Service primary care who had tried to stop an antidepressant, 79% reported withdrawal symptoms, 45% rated them moderately severe or severe, 20% had symptoms lasting more than three months and 10% for more than a year (Horowitz et al., 2025). Dr. Mark Horowitz, a co-author, is Outro Health's clinical co-founder.
NICE's 2022 depression guideline says withdrawal can sometimes be severe and last several weeks or occasionally several months, while also noting that most people stop antidepressants successfully (NICE, 2022). The most defensible inference from the evidence currently available is that short, mild withdrawal is real and common, and so is withdrawal lasting months, especially after long-term use. Neither experience is the "normal" one.
How Official Guidance Changed
In May 2019, the Royal College of Psychiatrists called for greater recognition that some people experience severe and long-lasting withdrawal symptoms on and after stopping antidepressants (Royal College of Psychiatrists, 2019). The same year, NICE amended its guideline to acknowledge that symptoms can last much longer, sometimes months or more, and be more severe for some patients, replacing wording that called them usually mild and self-limiting (Iacobucci, 2019).
You may still see the phrase "antidepressant discontinuation syndrome." The more accurate and honest term is antidepressant withdrawal. "Discontinuation syndrome" is a pharmaceutical-industry euphemism that shifts responsibility for the difficulty of stopping from the drug to the patient.
Who Is More Likely to Have Longer Withdrawal
No one can predict exactly how long withdrawal will last for you. A 2023 review did identify factors associated with a higher risk, while describing the evidence as limited (Horowitz et al., 2023):
- Longer time on an antidepressant, regardless of class (including SSRIs, SNRIs, etc.)
- Taking an SNRI, such as venlafaxine or duloxetine, or paroxetine
- Having had withdrawal symptoms before, after a missed dose or an earlier attempt to stop
- A higher dose, which showed a weaker association than the other factors
How you stop matters too. Stopping abruptly or in large steps is the reason NICE advises tapering in steps where each dose is a proportion of the previous one, with smaller reductions as the dose gets lower (NICE, 2022).
Duration of use has one of the clearest signals. In the 2025 primary-care survey, people who had taken antidepressants for more than two years before stopping were far more likely to experience a withdrawal syndrome and severe withdrawal than those who had taken them for under six months (Horowitz et al., 2025). If you started a medication a decade or two ago, at a different stage of life, your brain has had a long time to adapt. That does not mean a hard experience is inevitable. It means planning matters.
"the longer you're on these drugs, the harder they are to stop"
Dr. Mark Horowitz, Clinical Co-Founder of Outro Health (The Frontier Psychiatrists, 2025)
A Rough Picture of How Withdrawal Symptoms Unfold
There is no fixed calendar, and the pattern is highly individual. Still, many people describe something like this. Symptoms often begin within days of a dose reduction or a missed dose, sooner with shorter half-life drugs. For some, they fade over days or a few weeks. For many others, they settle into a longer stretch of good and bad days, and a smaller group develops protracted withdrawal lasting months or years, which the Maudsley Deprescribing Guidelines describe as long neglected and frequently misattributed to relapse or a new condition (Horowitz & Taylor, 2024). For a closer look at each stage, see our guide to the phases of SSRI withdrawal.
The symptoms themselves can be physical and emotional: dizziness, nausea, headache, fatigue, insomnia, vivid dreams, irritability, anxiety, low mood and tearfulness. Some are distinctive. In a 2024 survey of 1,148 people recruited through online withdrawal support groups, 76.8% reported electric shock sensations ("brain zaps") starting or getting worse after reducing or stopping an antidepressant, compared with 5.6% who had them in the weeks before they started the drug (Moncrieff et al., 2024).
Withdrawal or Relapse: Why the Difference Matters
How long withdrawal lasts often gets lost in a different question: is this withdrawal, or is the depression back? Withdrawal symptoms are different from a relapse. NICE advises that relapse does not usually happen as soon as someone stops or lowers an antidepressant, and withdrawal can include symptoms that are not typical of depression, such as dizziness or electric-shock sensations (NICE, 2022). Because withdrawal can also include low mood, anxiety and tearfulness, the two are easily confused. Getting it wrong can mean restarting a full dose "for life" when the real problem was the speed of the reduction.
| Feature | Withdrawal | Relapse |
|---|---|---|
| Usual onset | Often within days of a dose change, though it can be delayed by weeks or months | Does not usually appear as soon as a dose is lowered or stopped |
| Physical symptoms | Common: dizziness, nausea, electric-shock sensations, flu-like feelings | Less typical, apart from sleep and appetite changes |
| Emotional symptoms | Can include low mood, anxiety, irritability, crying spells | Resemble the episode that led to treatment |
| Feels like | New or different from your earlier experience | Familiar, like the original episode |
It also helps to know that depression is not a one-way street. Most people recover from depression within a year, including those with severe depression (Whiteford et al., 2013). Low mood after stopping is not, by itself, proof that you need the medication. That is a judgment to make with your clinician, looking at timing, symptoms and history together.
Delayed Onset Withdrawal
Withdrawal symptoms do not always arrive on schedule. They can be delayed for several weeks or even months after a dose reduction or the last dose, often called delayed onset withdrawal. It is best known with Prozac (fluoxetine), because its active metabolite, norfluoxetine, stays in the body for weeks. It also happens with shorter-acting SSRIs and SNRIs (Horowitz & Taylor, 2022). One hypothesis, noted in the Maudsley Deprescribing Guidelines, is that occupancy of the serotonin transporter in the brain falls more slowly than drug levels in the blood (Horowitz & Taylor, 2024).
This matters because late symptoms are the ones most often misread as relapse or as a new illness (Fava et al., 2015; Davies & Read, 2019). It also affects pacing: Horowitz and Taylor (2019) suggest waiting about four weeks after an SSRI reduction to watch for late effects, and the Maudsley Deprescribing Guidelines suggest six-to-eight-week gaps between some fluoxetine reductions for the same reason (Horowitz & Taylor, 2024). If new symptoms show up a month after a change, it is worth asking whether the change itself could be the cause.
Conclusion
There is no single answer to how long antidepressant withdrawal lasts. For some people it is a mild week or two. For many others it is months of uneven days, and for a smaller group it lasts a year or more. The research points the same way: longer use, certain drugs, past withdrawal and large or sudden reductions make a longer course more likely, and symptoms can start late enough to be mistaken for relapse.
What you can do is make the timeline visible. Keep track of when symptoms begin relative to each dose change, notice which ones feel new, and bring that record to your clinician. Please do not stop a medication suddenly without clinical support. If you are having thoughts of suicide or feel unsafe, call or text 988 in the US, or go to the nearest ER.
How Outro Health Helps When Withdrawal Takes Longer
Outro Health is a telehealth clinic built around the problem this article describes: withdrawal that does not follow the short timeline people were promised. After completing an evaluation, the Taper Management Program pairs you with one dedicated clinician trained in hyperbolic tapering. Your plan adapts to how you respond, with regular visits, between-visit messaging, symptom monitoring that helps separate withdrawal from relapse, and compounded small doses delivered when standard tablets cannot make the steps small enough. If your body needs to slow down, the taper slows down.
If you are still exploring, our guide to what an SSRI taper schedule can look like is a good next read. And if you would like to get off antidepressants, we're here when you need us.
Frequently Asked Questions
Can Antidepressant Withdrawal Last for Months?
Yes, for some people it can. A 2019 systematic review found it is not uncommon for symptoms to last several months (Davies & Read, 2019), and in a 2025 survey of 310 NHS primary-care patients, 20% had symptoms lasting more than three months and 10% for more than a year (Horowitz et al., 2025). Duration is highly individual: some people have mild symptoms for days or weeks, while longer use and past withdrawal raise the risk of prolonged symptoms.
Why Do Withdrawal Symptoms Sometimes Start Weeks After Stopping?
This is called delayed onset withdrawal. With Prozac (fluoxetine), the active metabolite norfluoxetine stays in the body for weeks, so symptoms can emerge late. It also happens with shorter-acting SSRIs and SNRIs, possibly because transporter occupancy in the brain falls more slowly than blood levels (Horowitz & Taylor, 2024). Late symptoms are often mistaken for relapse or a new illness, so it helps to tell your clinician when they began relative to your last dose change.
How Can I Tell If It's Withdrawal or Depression Coming Back?
Timing and the type of symptoms are the main clues. NICE advises that relapse does not usually happen as soon as someone lowers or stops an antidepressant, and withdrawal can include symptoms depression does not, such as dizziness or electric-shock sensations (NICE, 2022). Withdrawal can also be delayed for weeks or months after a dose change, so late symptoms are not automatically relapse. Symptoms that feel new or different point toward withdrawal; talk them through with your clinician.
Does a Drug's Half-Life Decide How Long Withdrawal Lasts?
No. Half-life shapes when acute symptoms tend to begin, which is why drugs that leave the body faster, such as paroxetine and venlafaxine, often cause symptoms sooner. But the drug clearing the body does not mean the brain's adaptations have reversed. Withdrawal can continue for weeks or months as the brain adjusts to the absence of the medication, so prolonged symptoms remain possible after the drug is gone (Horowitz & Taylor, 2024).
Is It Safe to Stop an Antidepressant Cold Turkey?
Stopping suddenly is not recommended. NICE's 2022 guideline advises tapering in steps where each dose is a proportion of the previous one, using smaller reductions as the dose gets lower, and notes that withdrawal can sometimes be severe and last several weeks or occasionally several months (NICE, 2022). Do not stop a medication suddenly without clinical support; make any change with your clinician. If you have thoughts of suicide, call or text 988 in the US.
Want to explore safe tapering?
Book an evaluation with an Outro clinician, trained in deprescribing.
The information provided on this page is for educational and informational purposes only and is not intended as medical advice. It should not be used to diagnose, treat, cure, or prevent any medical condition. Always seek the guidance of a qualified healthcare professional with any questions you may have regarding your health, medical condition, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. If you are experiencing a medical emergency, please call 911 (or your local emergency number) immediately.
- Davies, J., & Read, J. (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addictive Behaviors, 97, 111-121. https://doi.org/10.1016/j.addbeh.2018.08.027
- Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015). Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: A systematic review. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000370338
- Horowitz, M. A., Buckman, J. E. J., Saunders, R., Aguirre, E., Davies, J., & Moncrieff, J. (2025). Antidepressants withdrawal effects and duration of use: A survey of patients enrolled in primary care psychotherapy services. Psychiatry Research, 350, 116497. https://doi.org/10.1016/j.psychres.2025.116497
- Horowitz, M. A., Framer, A., Hengartner, M. P., Sørensen, A., & Taylor, D. (2023). Estimating risk of antidepressant withdrawal from a review of published data. CNS Drugs, 37(2), 143-157. https://doi.org/10.1007/s40263-022-00960-y
- Horowitz, M. A., & Taylor, D. (2019). Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, 6(6), 538-546. https://doi.org/10.1016/S2215-0366(19)30032-X
- Horowitz, M. A., & Taylor, D. (2022). Distinguishing relapse from antidepressant withdrawal: clinical practice and antidepressant discontinuation studies. BJPsych Advances, 28(5), 297-311. https://doi.org/10.1192/bja.2021.62
- Horowitz, M., & Taylor, D. M. (2024). The Maudsley Deprescribing Guidelines: Antidepressants, benzodiazepines, gabapentinoids and z-drugs. Wiley-Blackwell. https://doi.org/10.1002/9781394291052.mdg005
- Iacobucci, G. (2019). NICE updates antidepressant guidelines to reflect severity and length of withdrawal symptoms. BMJ, 367, l6103. https://doi.org/10.1136/bmj.l6103
- Meyer, J. H., Wilson, A. A., Sagrati, S., Hussey, D., Carella, A., Potter, W. Z., Ginovart, N., Spencer, E. P., Cheok, A., & Houle, S. (2004). Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: An [11C]DASB positron emission tomography study. American Journal of Psychiatry, 161(5), 826-835. https://doi.org/10.1176/appi.ajp.161.5.826
- Moncrieff, J., Read, J., & Horowitz, M. A. (2024). The nature and impact of antidepressant withdrawal symptoms and proposal of the Discriminatory Antidepressant Withdrawal Symptoms Scale (DAWSS). Journal of Affective Disorders Reports, 16, 100765. https://doi.org/10.1016/j.jadr.2024.100765
- National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NICE guideline NG222). https://www.nice.org.uk/guidance/ng222/chapter/Recommendations
- Royal College of Psychiatrists. (2019). Position statement on antidepressants and depression (PS04/19). https://www.rcpsych.ac.uk/docs/default-source/improving-care/better-mh-policy/position-statements/ps04_19---antidepressants-and-depression.pdf
- The Frontier Psychiatrists. (2025). Ending antidepressants: A conversation with Mark Horowitz, M.D. https://thefrontierpsychiatrists.substack.com/p/ending-antidepressants-a-conversation
- Whiteford, H. A., Harris, M. G., McKeon, G., Baxter, A., Pennell, C., Barendregt, J. J., & Wang, J. (2013). Estimating remission from untreated major depression: A systematic review and meta-analysis. Psychological Medicine, 43(8), 1569-1585. https://doi.org/10.1017/S0033291712001717
